San Diego, CALIFORNIA1 Active Studies

Familial Hypercholesterolemia Clinical Trials in San Diego, CALIFORNIA

Find 1 actively recruiting familial hypercholesterolemia clinical trials in San Diego, CALIFORNIA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
405
Enrolling

Recruiting Familial Hypercholesterolemia Studies in San Diego

About Familial Hypercholesterolemia Clinical Trials in San Diego

Familial hypercholesterolemia is a genetic condition causing very high LDL cholesterol levels from birth, dramatically increasing the risk of early heart disease. It affects about 1 in 250 people. Treatment includes high-intensity statins, PCSK9 inhibitors, and lifestyle modifications.

There are currently 1 familial hypercholesterolemia clinical trials recruiting participants in San Diego, CALIFORNIA. These studies are seeking a combined 405 participants. Research is being sponsored by AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.

Familial Hypercholesterolemia Clinical Trials in San Diego — FAQ

Are there familial hypercholesterolemia clinical trials in San Diego?

Yes, there are 1 familial hypercholesterolemia clinical trials currently recruiting in San Diego, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Diego?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Diego research site will contact you about next steps.

Are clinical trials in San Diego free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Diego studies also compensate for your time and travel.

What familial hypercholesterolemia treatments are being tested?

The 1 active trials in San Diego are testing new therapies including novel drugs, biologics, and treatment approaches for familial hypercholesterolemia.

Data updated March 2, 2026 from ClinicalTrials.gov